Introduction
The Gensini scoring system is an objective method to determine the severity of CAD according to angiographic findings. Furthermore, data about the association between the coronary scores and in-stent restenosis (ISR) in patients with ST-segment elevation myocardial infarction (STEMI) undergoing P-PCI is lacking. In this study we aimed evaluation of the angiographic restenosis rate at a 3-month follow-up, and to identify the relationship between ISR and the severity of coronary artery disease assessed by Gensini score and the patients’ characteristics those treated with BMS in p-PCI for acute STEMI.
Material and Methods
From 2004 to 2013, 372 consecutive patients presenting with first acute STEMI who were successfully treated with BMS by P-PCI within the 12 hours from the onset of symptoms and had an angiographic follow-up at 3-month included in our study. The severity of CAD was calculated by using Gensini score. We calculated Gensini score from recording which were taken before pPCI with incorporating the culprit lesion. Patients demographic variables, medical histories and clinical features, as well as in hospital major adverse events were obtained from the medical reports. Angiographically assessed ISR was defined as luminal narrowing of 50% or more occurring in segment inside the stent.
Material and Methods
From 2004 to 2013, 372 consecutive patients presenting with first acute STEMI who were successfully treated with BMS by P-PCI within the 12 hours from the onset of symptoms and had an angiographic follow-up at 3-month included in our study. The severity of CAD was calculated by using Gensini score. We calculated Gensini score from recording which were taken before pPCI with incorporating the culprit lesion. Patients demographic variables, medical histories and clinical features, as well as in hospital major adverse events were obtained from the medical reports. Angiographically assessed ISR was defined as luminal narrowing of 50% or more occurring in segment inside the stent.
Stay updated, free articles. Join our Telegram channel
Full access? Get Clinical Tree
